SHUN WO GROUP (01591) Announces Interim Results: Net Loss of HK$3.221 million, Narrowed by 80.2% Year-on-Year
SHUN WO GROUP (01591) announced its interim results for the six months ended September 30, 2026, with revenue of HK$96.31 million, up 22.33% year-on-year; net loss of HK$3.221 million, narrowed by 80.2% year-on-year; and loss per share of 0.6 HK cents.
SHUN WO GROUP (01591) announced its interim results for the six months ended September 30, 2026, with revenue of HK$96.31 million, up 22.33% year-on-year; net loss of HK$3.221 million, narrowed by 80.2% year-on-year; and loss per share of 0.6 HK cents.
The announcement stated that the significant increase in revenue was mainly attributable to the revenue stream generated from foundation projects awarded in early 2026 that have been recognized.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276): Fosrolapitant Palonosetron for Injection Receives Drug Registration Approval

SCHOLAR EDU (01769): Trustee purchases 110,000 shares under share award scheme

JPMorgan increases its long position in Cig Shanghai (06166) by approximately 816,800 shares at approximately HK$56.92 per share.
Jiangsu Hengrui Pharmaceuticals (01276): Fosrolapitant Palonosetron for Injection Receives Drug Registration Approval

SCHOLAR EDU (01769): Trustee purchases 110,000 shares under share award scheme

JPMorgan increases its long position in Cig Shanghai (06166) by approximately 816,800 shares at approximately HK$56.92 per share.






